A prospective 'PARP inhibitor' drug that has struggled to show effectiveness in clinical trials against cancers can be structurally modified to greatly increase its power to kill tumor cells, researchers say.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200410162426.htm
No comments:
Post a Comment